NCT05227261Completed
Early Detection of Five Common Cancers Using the ctDNA Analysing Test
Assessment of a Novel Blood Test in Early Detection of the Five Common Cancers Based on the Investigation of the Circulating Tumour DNA
Source: ClinicalTrials.gov · Last updated 18 Feb 2025
Brief summary (registry, in English)
This is a multi-centre, prospective cohort study, aiming to evaluate a blood test in early detection of the four common cancers, based on the investigation of the circulating tumour DNA (ctDNA). Primary objective: To evaluate the performance characteristics of the blood ctDNA test in early detecting cancers. Secondary objectives: * To evaluate the performance characteristics of the test in determining the origin of tumour, as compared to the findings of the imaging diagnostic tests. * To determine the risk of cancers development in the high-risk population, as compared to that in the moderate-risk group.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 9057 (actual)
- First submitted
- 26 Jan 2022
- Start date
- Apr 2022
- Primary completion date
- Apr 2023
- Lead sponsor
- Gene Solutions
- Diseases
- Lung cancer, Colorectal cancer, Liver and biliary tract cancer, Gastric and esophageal cancer
- NCT number
- NCT05227261
What you commit to
- Study type: Observational
- Participants enrolled: 9057
- From Apr 2022 to the primary completion date, Apr 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of cancer (cancer has either been confirmed or been treated within the past 3 years)
- History of blood transfusion or bone marrow transplantation within the past 3 years
Other
- Does not agree to participate in study
- The subject has clinical manifestations of pregnant.
Who the study is looking for
- Aged 40 or above at enrolment
- Neither clinical suspicion of cancer nor history of confirmed cancer has been reported
- Agree to be contacted at 6 months and 12 months following enrolment to collect information about general health status and progress of cancer (if possible)
- Provide written informed consent
Age in the registry: 40 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hanoi Medical University Coordinator of this site? Confirm its status | Hanoi | Vietnam | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.